Italian real-life experience with brentuximab vedotin: Results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

A. Broccoli, C. Pellegrini, A. Di Rocco, B. Puccini, C. Patti, G. Gini, D. Mannina, M. Tani, C. Rusconi, A. Romano, A. Vanazzi, B. Botto, C. Carlo-Stella, S. Hohaus, P. Musto, P. Mazza, S. Molica, P. Corradini, A. Fama, F. GaudioM. Merli, A. Gravetti, G. Gritti, A. Arcari, P. Tosi, A.M. Liberati, A. Pinto, V. Pavone, F. Gherlinzoni, V. Naso, S. Volpetti, L. Trentin, M.C. Goldaniga, M. Bonfichi, A. De Renzo, C. Schiavotto, M. Spina, S. Storti, A.M. Carella, V. Stefoni, L. Argnani, P.L. Zinzani

Research output: Contribution to journalArticle

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)1931-1935
Number of pages5
JournalHaematologica
Volume102
Issue number11
DOIs
Publication statusPublished - 2017

Keywords

  • brentuximab vedotin, adolescent
  • adult
  • aged
  • allogeneic stem cell transplantation
  • anaplastic large cell lymphoma
  • Article
  • blood toxicity
  • cancer recurrence
  • cancer survival
  • clinical article
  • computer assisted tomography
  • disease free survival
  • drug dose reduction
  • drug efficacy
  • drug safety
  • drug tolerability
  • erythema
  • female
  • human
  • infusion
  • Italy
  • male
  • median survival time
  • multicenter study
  • multiple cycle treatment
  • nausea
  • neurotoxicity
  • neutropenia
  • observational study
  • overall survival
  • phase 2 clinical trial (topic)
  • positron emission tomography
  • progression free survival
  • retrospective study
  • survival rate
  • treatment response
  • weakness

Cite this

Italian real-life experience with brentuximab vedotin: Results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma. / Broccoli, A.; Pellegrini, C.; Di Rocco, A.; Puccini, B.; Patti, C.; Gini, G.; Mannina, D.; Tani, M.; Rusconi, C.; Romano, A.; Vanazzi, A.; Botto, B.; Carlo-Stella, C.; Hohaus, S.; Musto, P.; Mazza, P.; Molica, S.; Corradini, P.; Fama, A.; Gaudio, F.; Merli, M.; Gravetti, A.; Gritti, G.; Arcari, A.; Tosi, P.; Liberati, A.M.; Pinto, A.; Pavone, V.; Gherlinzoni, F.; Naso, V.; Volpetti, S.; Trentin, L.; Goldaniga, M.C.; Bonfichi, M.; De Renzo, A.; Schiavotto, C.; Spina, M.; Storti, S.; Carella, A.M.; Stefoni, V.; Argnani, L.; Zinzani, P.L.

In: Haematologica, Vol. 102, No. 11, 2017, p. 1931-1935.

Research output: Contribution to journalArticle

Broccoli, A, Pellegrini, C, Di Rocco, A, Puccini, B, Patti, C, Gini, G, Mannina, D, Tani, M, Rusconi, C, Romano, A, Vanazzi, A, Botto, B, Carlo-Stella, C, Hohaus, S, Musto, P, Mazza, P, Molica, S, Corradini, P, Fama, A, Gaudio, F, Merli, M, Gravetti, A, Gritti, G, Arcari, A, Tosi, P, Liberati, AM, Pinto, A, Pavone, V, Gherlinzoni, F, Naso, V, Volpetti, S, Trentin, L, Goldaniga, MC, Bonfichi, M, De Renzo, A, Schiavotto, C, Spina, M, Storti, S, Carella, AM, Stefoni, V, Argnani, L & Zinzani, PL 2017, 'Italian real-life experience with brentuximab vedotin: Results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma', Haematologica, vol. 102, no. 11, pp. 1931-1935. https://doi.org/10.3324/haematol.2017.171355
Broccoli, A. ; Pellegrini, C. ; Di Rocco, A. ; Puccini, B. ; Patti, C. ; Gini, G. ; Mannina, D. ; Tani, M. ; Rusconi, C. ; Romano, A. ; Vanazzi, A. ; Botto, B. ; Carlo-Stella, C. ; Hohaus, S. ; Musto, P. ; Mazza, P. ; Molica, S. ; Corradini, P. ; Fama, A. ; Gaudio, F. ; Merli, M. ; Gravetti, A. ; Gritti, G. ; Arcari, A. ; Tosi, P. ; Liberati, A.M. ; Pinto, A. ; Pavone, V. ; Gherlinzoni, F. ; Naso, V. ; Volpetti, S. ; Trentin, L. ; Goldaniga, M.C. ; Bonfichi, M. ; De Renzo, A. ; Schiavotto, C. ; Spina, M. ; Storti, S. ; Carella, A.M. ; Stefoni, V. ; Argnani, L. ; Zinzani, P.L. / Italian real-life experience with brentuximab vedotin: Results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma. In: Haematologica. 2017 ; Vol. 102, No. 11. pp. 1931-1935.
@article{5601bbf0f4454f90b6cb94f549ceff7b,
title = "Italian real-life experience with brentuximab vedotin: Results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma",
keywords = "brentuximab vedotin, adolescent, adult, aged, allogeneic stem cell transplantation, anaplastic large cell lymphoma, Article, blood toxicity, cancer recurrence, cancer survival, clinical article, computer assisted tomography, disease free survival, drug dose reduction, drug efficacy, drug safety, drug tolerability, erythema, female, human, infusion, Italy, male, median survival time, multicenter study, multiple cycle treatment, nausea, neurotoxicity, neutropenia, observational study, overall survival, phase 2 clinical trial (topic), positron emission tomography, progression free survival, retrospective study, survival rate, treatment response, weakness",
author = "A. Broccoli and C. Pellegrini and {Di Rocco}, A. and B. Puccini and C. Patti and G. Gini and D. Mannina and M. Tani and C. Rusconi and A. Romano and A. Vanazzi and B. Botto and C. Carlo-Stella and S. Hohaus and P. Musto and P. Mazza and S. Molica and P. Corradini and A. Fama and F. Gaudio and M. Merli and A. Gravetti and G. Gritti and A. Arcari and P. Tosi and A.M. Liberati and A. Pinto and V. Pavone and F. Gherlinzoni and V. Naso and S. Volpetti and L. Trentin and M.C. Goldaniga and M. Bonfichi and {De Renzo}, A. and C. Schiavotto and M. Spina and S. Storti and A.M. Carella and V. Stefoni and L. Argnani and P.L. Zinzani",
year = "2017",
doi = "10.3324/haematol.2017.171355",
language = "English",
volume = "102",
pages = "1931--1935",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "11",

}

TY - JOUR

T1 - Italian real-life experience with brentuximab vedotin: Results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

AU - Broccoli, A.

AU - Pellegrini, C.

AU - Di Rocco, A.

AU - Puccini, B.

AU - Patti, C.

AU - Gini, G.

AU - Mannina, D.

AU - Tani, M.

AU - Rusconi, C.

AU - Romano, A.

AU - Vanazzi, A.

AU - Botto, B.

AU - Carlo-Stella, C.

AU - Hohaus, S.

AU - Musto, P.

AU - Mazza, P.

AU - Molica, S.

AU - Corradini, P.

AU - Fama, A.

AU - Gaudio, F.

AU - Merli, M.

AU - Gravetti, A.

AU - Gritti, G.

AU - Arcari, A.

AU - Tosi, P.

AU - Liberati, A.M.

AU - Pinto, A.

AU - Pavone, V.

AU - Gherlinzoni, F.

AU - Naso, V.

AU - Volpetti, S.

AU - Trentin, L.

AU - Goldaniga, M.C.

AU - Bonfichi, M.

AU - De Renzo, A.

AU - Schiavotto, C.

AU - Spina, M.

AU - Storti, S.

AU - Carella, A.M.

AU - Stefoni, V.

AU - Argnani, L.

AU - Zinzani, P.L.

PY - 2017

Y1 - 2017

KW - brentuximab vedotin, adolescent

KW - adult

KW - aged

KW - allogeneic stem cell transplantation

KW - anaplastic large cell lymphoma

KW - Article

KW - blood toxicity

KW - cancer recurrence

KW - cancer survival

KW - clinical article

KW - computer assisted tomography

KW - disease free survival

KW - drug dose reduction

KW - drug efficacy

KW - drug safety

KW - drug tolerability

KW - erythema

KW - female

KW - human

KW - infusion

KW - Italy

KW - male

KW - median survival time

KW - multicenter study

KW - multiple cycle treatment

KW - nausea

KW - neurotoxicity

KW - neutropenia

KW - observational study

KW - overall survival

KW - phase 2 clinical trial (topic)

KW - positron emission tomography

KW - progression free survival

KW - retrospective study

KW - survival rate

KW - treatment response

KW - weakness

U2 - 10.3324/haematol.2017.171355

DO - 10.3324/haematol.2017.171355

M3 - Article

VL - 102

SP - 1931

EP - 1935

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 11

ER -